Kingdon Capital is the famous Corporate Investor, which was founded in 1983. The leading representative office of defined Corporate Investor is situated in the New York. The company was established in North America in United States.
The higher amount of exits for fund were in 2015. Considering the real fund results, this Corporate Investor is 0 percentage points less often commits exit comparing to other organizations. This Kingdon Capital works on 51 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2017. The fund is constantly included in less than 2 investment rounds annually.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Kingdon Capital, startups are often financed by North Bridge Venture Partners & Growth Equity, Battery Ventures, Viola Ventures. The meaningful sponsors for the fund in investment in the same round are Viola Ventures, Van Wagoner Ventures, LLC, North Bridge Venture Partners & Growth Equity. In the next rounds fund is usually obtained by Wellington Financial, Visa International Service Association, Viola Ventures.
Among the most successful fund investment fields, there are E-Commerce, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Luminous Networks, SandCraft, Napo Pharmaceuticals. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
Related Funds
Funds with similar focus
Fund Name | Location |
Ali Chuangtou | China, Hangzhou, Zhejiang |
AVP Holdings | - |
Bonsal Capital | Baltimore, Maryland, United States |
Chant Venture Fund | Australia, New South Wales, Sydney |
Coeur Mining Inc. | Chicago, Illinois, United States |
Cortado Ventures | Oklahoma, Oklahoma City, United States |
Farnam Street Financial | Minnesota, Minnetonka, United States |
Freelands Group | - |
Guardian Life Insurance Company - Dental Service Organization | New York, New York, United States |
Hasso Plattner Institute | Brandenburg, Germany, Potsdam |
India Technology Fund | - |
Jinpengjia Holdings | - |
KCE | - |
Linghao Touzi | China, Shanghai |
MVP Capital | Pennsylvania, Radnor, United States |
Shanda Capital | China, Shanghai |
Shanghai Pu Xin Fund Management | Changning, China, Shanghai |
St. Paul Fire and Marine Insurance Company | Minnesota, Saint Paul, United States |
Standard Life | City of Edinburgh, Scotland, United Kingdom |
Westlake Ventures | California, Redwood City, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Sapience Therapeutics | $41M | 31 May 2022 | New York, United States | ||
Shoreline Biosciences | $140M | 02 Nov 2021 | San Diego, California, United States | ||
CeQur | $115M | 13 Apr 2021 | Lucerne, Switzerland | ||
Imago BioSciences | $80M | 19 Nov 2020 | California, United States | ||
Bill Me Later | $27M | 01 Mar 2006 | Maryland, United States | ||
$4M | 14 Aug 2002 | California, United States | |||
SandCraft | $19M | 01 Jun 2000 | San Jose, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Sapience Therapeutics | $41M | 31 May 2022 | New York, United States | ||
Shoreline Biosciences | $140M | 02 Nov 2021 | San Diego, California, United States | ||
CeQur | $115M | 13 Apr 2021 | Lucerne, Switzerland | ||
Imago BioSciences | $80M | 19 Nov 2020 | California, United States | ||
Bill Me Later | $27M | 01 Mar 2006 | Maryland, United States | ||
$4M | 14 Aug 2002 | California, United States | |||
SandCraft | $19M | 01 Jun 2000 | San Jose, California, United States |